About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Pfizer's West Side Story: How "the Sharks" Sold Bextra Off-Label

By Jim Edwards | Sep 3, 2009

Pfizer had a sales team in Florida that called themselves “the Sharks” as they promoted Bextra off-label, according to documents filed in the one of the cases that led to yesterday’s $2.3 billion settlement.

South Florida district sales manager Matthew Lustig addressed his team as “the Sharks,” according to emails filed in the case (hosted on law firm Phillips & Cohen’s web site). Here’s one (click to enlarge):

It was not the only Pfizer sales team with a cute nickname. BNET previously noted the existence of “the Highlanders,” a team that sold Bextra in Brooklyn, N.Y. A representative said:

Pfizer denies all federal, state and qui tam allegations, with two exceptions. We acknowledge certain improper actions related to the past promotion of Bextra and Zyvox. Beyond those two exceptions we deny all federal and state and qui tam claims.

Lustig also rewarded sales reps who persuaded doctors to use Bextra off-label in surgical protocols with “Ace Points,” that were worth money. In one email he praised sales rep Roger Catlett:

“Great job Roger! 5000 Ace Points [about $50.00] on the way.”

John Kopchinski was the sales rep who won $52 million in his cut of the settlement, as a whistleblower who brought the off-label sales to the government’s attention. He was one of the Sharks.

In Kopchinksi’s district, doctors were given article reprints by sales reps addressing off-label uses, the suit alleges. The articles’ first page indicated what Bextra was, and was not, approved for. But Pfizer had a way around that, according to the complaint:

Pfizer sales representatives were instructed, when leaving these reprints with doctors, to fold this first page over, so that it became the last page, not the first page, of the reprint as it was presented to the physicians.

Pfizer also paid doctors to do pretty much everything, the complaint alleges. Here’s menu of what was on offer:

$250 to $1,500 for travel and meal expenses for conferences in luxury hotels. On these trips, golf was available. One email to the Sharks from Lustig said:

We have a number of people going to this meeting. If any of them want to golf let me know, I will be there.

$500 for a doctor to do a clinical paper review with a rep — where the rep already was familiar with the material being “reviewed.”

$1,000 for a “preceptorship,” in which a rep would shadow a doctor for a day.

$250-$1000 to attend journal clubs, where a handful of doctors would discuss an article.

$250-$1,000 to make a presentation to a journal club.

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Ex-exec: Off-label promo 'part of Pfizer culture'

    Fierce Pharma - 150 days 21 hours 30 minutes ago

    The ex-Pfizer sales manager sentenced for off-label promotion of the Bextra painkiller told Massachusetts officials that the company not only knew about her off-label activities, but encouraged them. According to a sentencing memo filed in federal district court (and obtained by BNet Pharma), off-label promotion of Bextra was "part of the Pfizer...

  • Pfizer's Off-Label Bextra Team Was Called "The Highlanders"

    BNET Pharma - 147 days 19 hours 27 minutes ago

    The Pfizer sales team leader convicted of deleting computer documents in a federal investigation of off-label Bextra sales called his staff “The Highlanders,” according to an email produced in Massachusetts federal district court. The nickname is a reference to a movie and TV show about an immortal Scottish swordsman from the 1500s who must...

  • Pfizer Exec Gets 3 Months' Home Confinement for Off-Label Bextra Sales

    BNET Pharma - 123 days 15 hours 21 minutes ago

    Thomas Farina, the Pfizer sales manager convicted for his role in leading “The Highlanders,” a team of rogue drug reps who promoted Bextra for off-label use in Brooklyn, N.Y., was sentenced to home confinement and electronic monitoring — probably via ankle bracelet — for six months. He will remain on probation for three years. No...

  • Document Shows Rogue Bextra Operation Inside Pfizer

    BNET Pharma - 228 days 20 hours 10 minutes ago

    The "information" document filed by federal prosecutors against Mary Holloway describes what appears to be a rogue sales unit inside Pfizer dedicated to selling the painkiller Bextra off-label and at unapproved doses. Holloway is believed to be a former Pfizer employee (see Peter Rost's join-the-dots conclusion) although documents in the case...

  • M.D. pilot made off-label Pfizer rounds

    Fierce Pharma - 63 days 21 hours 31 minutes ago

    A penchant for helicopters characterizes forensic psychiatrist Neil Kaye, M.D., a prominent player in the recent $2.3 billion Pfizer off-label marketing settlement. According to Bnet, high-roller Kaye allegedly received $4,000 a day to promote Geodon, an antipsychotic drug, in addition to expense reimbursement for use of his own helicopter to...

Links from the Web Buzz:
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement